The circulating hormone angiotensin II is an important humoral factor regulating cardiovascular and body fluid and electrolyte homeostasis. Potent direct constrictor actions on the vasculature, stimulation of the sodium-retaining hormone aldosterone from the adrenal cortex, generation of thirst and sodium appetite, release of the urine-concentrating hormone vasopressin, intrarenal regulation of tubular-glomular balance, and feedback inhibition of renal renin release are just some of the well recognized actions of this circulating octapeptide. But angiotensin II may have further roles in regulating body fluid homeostasisnot as a blood-borne hormone, but as a neuropeptide generated within the central nervous system (CNS), where it may act as a neurotransmitter or modulator of neural function to influence thirst, vasopressin secretion, renin release, sodium excretion, and body temperature.
cellular site of angiotensinogen synthesis in the brain appears to be the astrocyte [1] [2] [3] , although there are some suggestions that neuronal synthesis of angiotensinogen may also occur [4] . Brain regions in which angiotensinogen and its messenger RNA (mRNA) have been localized are widespread within the CNS, though a preponderance of these molecules may exist in the diencephalon and hindbrain [2, 3] . Angiotensinogen is constitutively secreted into the brain interstitium and is a component of cerebrospinal fluid [5] .
Angiotensin
Angiotensin II and III, respectively the biologically active octapeptide and the heptapeptide through which angiotensinergic mechanisms in the brain are thought to be transmitted, are found in neuronal cell bodies and fibers in several regions of the CNS. Immunohistochemical studies [6, 7] , which used antisera that did not distinguish between angiotensin II and angiotensin III, show that the sites in the brain containing the greatest number of angiotensin-containing neurons are the hypothalamic paraventricular (PVN) and supraoptic nuclei, the subfornical organ, the nucleus of the solitary tract, and periventricular regions. Several angiotensin-containing fiber pathways have been identified, the most prominent being bundles of longitudinally directed axons in the periventricular fiber system and medial forebrain bundle. The richest angiotensincontaining terminal fields were observed in the central nucleus of the amygdala, the bed nucleus of the lamina terminalis, the lateral parabrachial nucleus, parts of the thalamus, periventricular parts of the hypothalamus, and the substantia gelatinosa of the spinal cord [6] .
Electron microscopy studies of the rat brain show that angiotensin II immunoreactivity is observed in presynaptic vesicles, consistent with a neurotransmitter function for this octapeptide. Furthermore, angiotensin-like immunoreactivity has been localized to neurosecretory vesicles in nerve terminalis. These were found in the vicinity of the perivascular spaces surrounding fenestrated blood vessels in circumventricular organs such as the median eminence and subfornical organ [7, 8] .
Angiotensin receptors
Angiotensin receptors, both the AT 1 and AT 2 subtypes, are in several regions of the central nervous system. Initially, in vitro autoradiographic binding techniques were used to map the distribution of these receptors in the brains of several mammalian species, including humans [9] [10] [11] [12] [13] . These investigations revealed that many of the sites in the CNS that contained high levels of angiotensin receptors were regions that played important roles in the regulation of body fluid and electrolyte homeostasis and of the cardiovascular system (Fig. 1) . These sites included the supraoptic and paraventricular nuclei of the hypothalamus, the lamina terminalis, the bed nucleus of the stria terminalis, the parabrachial nucleus, the nucleus of the solitary tract, the rostral and caudal ventrolateral medulla, and the intermediolateral cell column in the spinal cord. Subsequent displacement studies with specific nonpeptide antagonists of the AT 1 and AT 2 receptor subtypes, immunohistochemistry, and in situ hybridization show that the AT 1 receptor is the predominant subtype in all the above-mentioned sites [14] [15] [16] [17] [18] [19] [20] . In rodents, the AT 1 receptor has been classified further into AT 1A and AT 1B receptors, which differ in only a few amino acids.
Processing enzymes
The protease renin, which splits off the decapeptide angiotensin I, is found within the CNS, though both renin and the mRNA encoding it are expressed at exceedingly low levels [21] . As a result, doubts have been raised as to whether renin is the enzyme in the brain involved in the generation of angiotensin I there. Furthermore, the anatomical localization of renin is less clear than other components of this system. By contrast, angiotensin converting enzyme (ACE), Fig. 1 . Diagram of the main sites of angiotensin AT 1 receptors in the mammalian brain. The receptor locations are projected onto a midsagittal diagram of the rat brain, though some sites (e.g., supraoptic nucleus do not exhibit AT 1 receptors in rat brain). Am, amygdala; Arc, arcuate nucleus; AP, area postrema; AVPO, anteroventral preoptic nucleus; BST, bed nucleus of the stria terminalis; DMV, dorsal motor nucleus of the vagus; LPB, lateral parabrachial nucleus; LOT, nucleus of the lateral olfactory tract; LS; lateral septum; ME, median eminence; MnPO, median preoptic nucleus; NTS, nucleus of the solitary tract; OB, olfactory bulb; OVLT, organum vasculosum of the lamina terminalis; PeV, periventricular nucleus; PVN, hypothalamic paraventricular nucleus; RVLM/CVLM, rostral and caudal ventrolateral medulla; sc, superior colliculus; SFO, subfornical organ; SNC, substantia nigra pars compacta; SON, supraoptic nucleus; VLG, ventrolateral geniculate nucleus.
which generates angiotensin II from angiotensin I, is widely distributed throughout many brain regions and is found at especially high concentrations in the choroid plexus, subfornical organ, organum vasculosum of the lamina terminalis (OVLT), and median eminence [22, 23] . Aminopeptidase A, which processes angiotensin II to angiotensin III, and aminopeptidase N, which breaks down angiotensin III, are also present in the brain [24] .
Evidence of Central Angiotensinergic Influences on Body Fluids
Neuroanatomical evidence of angiotensinergic terminals and angiotensin receptors in many brain regions subserving body fluid homeostasis leads to the sugestion that central angiotensinergic pathways mediate several homeostatic mechanisms. In particular, the location of these angiotensin receptors behind the blood-brain barrier and the lack of penetration of this barrier by blood-borne angiotensin II support the idea that the endogenous ligand for these receptors is derived from within the brain instead of from the bloodstream. This latter assertion must be qualified, however, when considering the AT 1 receptors in high concentrations in the subfornical organ, OVLT, median eminence, and area postrema. Neuronal elements within these circumventricular organs are exposed to blood-borne angiotensin II because of a lack of bloodbrain barrier there [25, 26] . There is strong evidence to support the view that blood-borne angiotensin stimulates neurons within these circumventricular organs, thereby activating several neural pathways. These pathways may influence water drinking, salt hunger, vasopressin secretion, adrenocorticotropic hormone (ACTH) release, inhibition of renin secretion from the kidney, and autonomic functions [27] . Notwithstanding the strong evidence that circulating angiotensin has major actions on neurons in the circumventricular organs, it is also possible, and indeed very likely, that there are angiotensinergic neural inputs of central origin into these neurons, which also participate in the central regulation of body fluid homeostasis. The subsequent sections in this brief review will consider these and other central angiotensinergic pathways that are activated by neurally derived angiotensin II and III.
Role in water intake
The rapid and large volume of water drunk by animals very soon after an injection of angiotensin II into the cerebral ventricles or the preoptic region of the brain is a clear indication that central angiotensinergic mechanisms may influence thirst [28] [29] [30] . That ablation of the subfornical does not inhibit the water intake in response to intracerebroventricular (ICV) injection of angiotensin II, despite blocking the dipsogenic action of systemically infused angiotensin II [31, 32] shows that angiotensin II can act at another region of the brain that lies behind the blood-brain barrier to stimulate drinking. Ablation of the anteroventral wall of the third ventricle (AV3V) of rat brain abolishes drinking in response to ICV angiotensin II [32] , and it is likely that AT 1 receptors, mainly in the median preoptic nucleus, which is a component of the AV3V region, mediate drinking induced by ICV infusion of angiotensin II. Data supporting this proposition: (1) Direct injection of angiotensin II into the median preoptic nucleus, which stimulates drinking [33]; (2) This nucleus is rich in both angiotensin-containing nerve terminals and AT 1 receptors [6, 17] ; (3) ICV injection of angiotensin II stimulates many neurons in the median preoptic nucleus, as shown by the resultant expression of c-fos there [34, 35] , and causes water drinking and several other responses; (4) The drinking that is induced by ICV angiotensin II is abolished by ablation of the median preoptic nucleus [36] . It has been proposed that neurons in the subfornical organ that are stimulated by circulating angiotensin II have efferent axonal connections with neurons in the median preoptic nucleus that subserve thirst [37] . This neural connection between subfornical organ and median preoptic nucleus may be utilizing angiotensin II as a neurotransmitter [37] .
Recent studies have used ICV injections of antisense oligonucleotides complementary in nucleotide sequence to the mRNA encoding the first four amino acids of angiotensinogen to block cerebral production of angiotensinogen in rat brain. This central antisense treatment (but not a peripheral injection of antisense) greatly reduced the water intake in response to ICV injection of renin, indicating that there were probably reduced levels of its substrate, angiotensinogen, in the critical brain sites as a result of antisense treatment [38] . Furthermore, the dipsogenic response to the subcutaneous injection of isoproterenol was inhibited by such antisense treatment, but other dipsogenic responses (e.g., drinking in response to carbachol and water deprivation or ICV angiotensin II) were unaffected [38] . Drinking in response to subcutaneous isoproterenol is considered to be dependent on increased secretion of renin from the kidney and to be mediated by raised circulating angiotensin levels [39] . The increased circulating angiotensin II would act on neurons in the subfornical organ to activate thirst pathways. Thus the inhibition of isoproterenol-induced drinking by central antisense treatment with the aim of reducing angiotensin levels within the brain is evidence that is consistent with a central angiotensinergic neural pathway being activated by circulating angiotensin II targeting its receptors in the subfornical organ.
Vasopressin secretion
The administration of angiotensin II into the cerebrospinal fluid of the lateral or third cerebral ventricles stimulates the secretion of vasopressin [40, 41] . In the rat, the vasopressin-secreting neurons of the hypothalamic supraoptic and paraventricular nuclei do not appear to exhibit angiotensin receptors [15] ; therefore it is unlikely that angiotensin is exerting its actions directly on the vasopressin-secreting neurons in this species. Moreover, the ablation of tissue in the anterior wall of the third cerebral ventricle prevents angiotensin-induced vasopressin release [42] . Since there are direct neural inputs to the vasopressin-secreting cells from this region [43] (which is rich in angiotensin receptors), and the administration of angiotensin blockers into the median preoptic nucleus prevents the stimulation of magnocellular neurons in the paraventricular nucleus by stimulation of the subfornical organ [44] , it is very likely that an angiotensinergic synapse in the median preoptic nucleus has a role in vasopressin release. The nucleus of the solitary tract and the A1 cells of the caudal ventrolateral medulla, other regions of the hindbrain rich in angiotensin receptors [27], also send direct neural inputs to the supraoptic and paraventricular nuclei [43] , and it is possible that they may also be sites at which angiotensin acts as a neurotransmitter to stimulate vasopressin secretion.
Renal sodium excretion
It has been known for many years that ICV administration of angiotensin II causes a large increase in sodium excretion by the kidney in several different mammals [40, [45] [46] [47] . The signal to the kidney that mediates this central action of angiotensin II remains to be conclusively identified. The suppression of renal sympathetic nerve activity [48] , reduced plasma renin concentration [48, 49] , increased plasma vasopressin levels [49] , and increased arterial pressure all occur concomitantly with the natriuretic reponse following ICV injection of angiotensin II [40] and may have roles in mediating the angiotensin-induced natriuresis. Alternatively, it is possible that a natriuretic agent is released into the circulation to induce the natriuresis. Whether there is a physiological role for a central angiotensinergic synapse in regulating sodium excretion remains to be determined. Studies of the effects of centrally administered angiotensin receptor antagonists on sodium excretion during various physiological conditions should be helpful in answering this question.
Renin secretion by the kidney
Besides the direct inhibitory effect that blood-borne angiotensin II has on renin secretion by the kidney, there is evidence that angiotensin acts centrally to inhibit renal renin release. The ICV administration of renin or angiotensin II reduces plasma renin activity, principally because renin secretion from the kidney is depressed [49-51]. The administration of angiotensin II into the cerebral ventricles also causes reduced renal sympathetic nerve activity [48] , making it likely that this is the reason renin secretion falls. It has been proposed also that baroreceptor activation, secondary to an increase in arterial pressure, further reduces renal nerve activity and renin levels. However, there is clearly a baroreceptor-independent component of the inhibition. Our results in Na-depleted sheep showed that the ICV infusion of angiotensin II caused a pronounced reduction of renin secretion without increasing arterial blood pressure [50] . We have observed that ICV infusion of hypertonic saline also depresses plasma renin levels in Na-depleted animals without increasing blood pressure. This effect is blocked by centrally administered losartan, suggesting that an angiotensinergic pathway within the brain influences renin secretion [52] . That this pathway is active during the condition of sodium depletion is suggested by the marked increase in plasma renin levels that occurs following ICV infusion of the AT 1 antagonist, losartan, in Na-depleted sheep [50] .
Osmoregulatory responses
Intracerebroventricular administration of hypertonic saline stimulates several responses-water drinking, vasopressin secretion, natriuresis, reduced renin secretion, reduced renal sympathetic nerve activity, and a pressor response-all of which are similar to the responses obtained when angiotensin II is infused into the brain [53] [54] [55] . Recent studies in rats and sheep show that central administration of the AT 1 receptor antagonist, losartan, blocks all these responses to ICV hypertonic saline, indicating a central angiotensinergic influence in osmoregulation [52, [56] [57] [58] [59] [60] . Moreover, ICV administration of losartan in cattle reduces an osmotically dependent drinking response, specifically, the drinking that follows water deprivation [61] . These results suggest that central angiotensinergic pathways have a role in a wide range of homeostatic functions relating to osmoregulation.
Centrally mediated responses to circulating relaxin
Relaxin is a hormone of pregnancy secreted by the corpus luteum of the ovary during pregnancy [62] . Besides the actions on reproductive tissues such as the pubic symphysis, uterus, and cervix, relaxin exerts actions on the CNS to influence bodily fluid balance [63] . These actions include the stimulation of vasopressin secretion and water drinking. Either ICV or systemic administration of relaxin stimulates drinking and vasopressin secretion in the rat [64] [65] [66] [67] . These actions of relaxin are very likely to be mediated via actions on neurons in the subfornical organ and OVLT, which are sites of high-affinity relaxin binding [68] and which, lacking a blood brain barrier, are exposed to circulating relaxin. Indeed, intravenous and ICV infusion of relaxin both stimulate neurons in the subfornical organ and OVLT, as shown by the expression of c-fos [69, 70] .
Recent work has shown that a blockade of central angiotensin receptors with peptide antagonists such as saralasin inhibit the vasopressin release and water drinking in response to centrally administered relaxin [64, 71] . Furthermore, ICV administration of the AT 1 receptor antagonist, losartan, causes pronounced inhibition of the water drinking that results from either intravenous or ICV relaxin [66] . Thus it seems that neural pathways originating in the subfornical organ and OVLT, which are activated by relaxin, utilize angiotensin at some point to transmit their signals to influence water drinking and vasopressin secretion. This is the same as the results observed with central stimulation with hypertonic saline, raising the possibility that relaxin and hypertonic saline transmit their neural signals via the same angiotensinergic neural pathways.
Salt appetite
With very few exceptions, the central administration of angiotensin II stimulates large intakes of both water and sodium salts [72] . Relative to the rapid increase in water intake, the increase in salt intake caused by centrally administered angiotensin II often occurs more slowly. The long delay has been taken as evidence that the increase in sodium intake is not entirely due to the actions of angiotensin II on the neurons subserving salt hunger. Instead, the increase in sodium intake, at least in part, is seen as a consequence of some other action of angiotensin II, e.g., increased sodium loss [45] . In mice [73] , however, a clear and unequivocal increase in sodium intake caused by long-term ICV infusion of angiotensin II was shown not to be secondary to sodium loss. In these experiments, sodium was not made available during the first 4 d of a 7-d ICV infusion of angiotensin II. When sodium was returned on the fifth day of infusion, the mice drank 15 to 20 times the amount of sodium lost in urine during the first 4 d of infusion.
Evidence that brain angiotensin II is involved in the sodium appetite of the sodium-depleted rat has been reported by Sakai and his co-workers [74, 75] . They have shown that the peripheral administration of antagonists of the renin-angiotensin system to rats, which completely block the peripheral but not the central actions of angiotensin II, do not influence sodium intake, i.e., only when the central actions of angiotensin II are blocked is sodium appetite decreased or abolished. In the baboon, sodium appetite subsequent to sodium depletion is completely blocked by ICV administration of the AT 1 antagonist ZD7155. Thus in the baboon it is possible that sodium appetite subsequent to Na depletion is entirely mediated by brain angiotensin II [76] . However, in ruminants, while circulating angiotensin II may have a role in the generation of sodium hunger [77] , the ICV administration of various agents that interfere with the formation or action of central angiotensin II, e.g., captopril or losartan, do not decrease the Na intake of Na-depleted sheep [78] or cows [77] . Recent experiments in Na-depleted sheep have demonstrated that brain angiotensin II may be part of the mechanism by which changes in brain extracellular fluid Na concentration influence Na appetite. ICV infusion of losartan not only attenuates the increase in water intake, but it also blocks the reduction in Na intake caused by the ICV infusion of hypertonic NaCl in Na-depleted sheep [78] ; i.e., the ICV infusion of losartan reduced water intake but increased Na intake to control level. Thus in contrast to rats and baboons, the central angiotensinergic mechanisms may have a role in inhibitory mechanisms influencing sodium appetite in sheep.
Thermoregulatory cooling
Thermoregulatory responses to increased body temperature in many mammals rely largely on evaporative cooling. This results in body fluid loss in the form of sweat, saliva, or respired air, depending on the species. As such, thermoregulation is closely linked with body fluid homeostasis. The infusion of angiotensin into the lateral cerebral ventricle results in reduced body temperature [79] . In a recent study, we tested the effect of central administration of the AT 1 receptor antagonist, losartan, on homeostatic responses to exposure to a hot (39°C) environment for 1 h. We observed that rats treated with ICV losartan had a greater increase in core body temperature than control rats did, which were exposed to the same hot environment but were given artificial cerebrospinal fluid infusions [80] . Both losartan-treated and control animals lost identical amounts of body weight, indicating that the thermoregulatory spreading of saliva on fur was not affected by the losartan treatment. One possibility that may explain this effect is that centrally administered losartan impairs the redistribution of blood flow from the viscera to the skin, because there is evidence that central losartan reduces splanchnic nerve activity in heated rats [81] . As a result, the reduced redistribution of blood flow from viscera to skin could reduce radiation of heat from the rat's body.
Besides measuring the effects of ICV losartan on body temperature, we measured the volumes of water drunk by both groups of rats in the 2 h following their heat exposure. The water intake of the losartan-treated rats was severely depressed in comparison with the control rats treated with artificial CSF [80] . The rats did not appear to be nonspecifically debilitated by the losartan treatment because both groups drank similar amounts of water in response to ICV injection of the cholinergic agonist, carbachol. Earlier work showed that drinking following thermally induced dehydration is secondary to the resulting hypertonicity of body fluids [82] . Our results are therefore consistent with the ideas put forward in a preceding paragraph that central angiotensinergic pathways mediate osmoregulatory drinking.
Conclusion
In conclusion, the work that has been reviewed here shows that there is now much evidence to demonstrate that angiotensin, generated and acting within the brain, has an important role in the control of body fluid homeostasis. Homeostatic responses that may be influenced by angiotensinergic neural pathways include thirst, vasopressin secretion, renin secretion, renal Na excretion, increased arterial pressure, and thermoregulatory adjustments. Systemic stimuli that may activate central angiotensinergic pathways include plasma hypertonicity and circulating hormones such as angiotensin II or relaxin. There is also evidence that brain angiotensinergic pathways have a role in regulating arterial pressure [83] [84] [85] . Several gaps in our knowledge of these angiotensinergic pathways still exist and await further elucidation. In particular, it will be important to determine whether angiotensinogen, which is synthesized in glial cells in the brain, is the precursor of angiotensin II or III that may be utilized by neurons as a neurotransmitter or neuromodulator. If it is, how does this come about? Furthermore, the specific sites where angiotensin is acting within polysynaptic neural pathways mediating homeostatic function need more exact definition. 
